KINSHASA, Democratic Republic of the Congo / RankWire.AI / – Health authorities in the Democratic Republic of the Congo have launched a targeted Ebola vaccination initiative in Kisangani, the administrative center of Tshopo Province, to combat what is now the country’s most severe outbreak on record. Frontline healthcare workers, emergency response personnel, and individuals who have had direct contact with confirmed cases are being prioritized during the initial phase of the deployment. Health Minister Roger Kamba confirmed that the government initiated the immunization campaign utilizing doses of the Ervebo vaccine to safeguard frontline personnel operating across impacted eastern provinces.
Official epidemiological data indicates that the ongoing outbreak has spread across six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Public health figures published by the Ministry of Public Health and Prevention show that the country has recorded 5,713 confirmed cases and 2,744 deaths. The current overall case fatality rate among confirmed patients stands at approximately 48%.
This public health crisis has prompted international organizations, including the World Health Organization, to assist local medical teams with logistical support, laboratory testing, and vaccine distribution efforts. Authorities are administering the Ervebo vaccine under a compassionate-use protocol while researchers collect observational data to assess its effectiveness against the circulating viral strain in the region. DR Congo initiates Ebola vaccination efforts as health workers expand ring-vaccination strategies around identified infection clusters to break viral transmission chains.
Ebola Vaccination Campaign Launched by DR Congo in the Eastern Provinces
Operational challenges, including regional infrastructure issues, ongoing security risks, and high population mobility across border districts, complicate logistical efforts. Cold-chain supply networks have been established in Kisangani to preserve the ultra-low temperatures needed for vaccine storage before distribution to remote health zones. DR Congo has launched Ebola vaccination activities, with civil defense and community health workers conducting outreach to enhance disease surveillance and reporting systems.
Epidemiologists from the Africa Centres for Disease Control and Prevention are working alongside local teams to monitor adverse reactions and assess immune responses among vaccinated populations. Officials highlighted that early clinical detection, combined with isolation and supportive treatment, remains critical to improving patient outcomes. Additional vaccine shipments are expected to arrive as regional distribution coverage broadens to secondary health districts.
Kisangani Acts as Central Hub for Ebola Vaccine Distribution in the Region
National teams continue expanding contact-tracing efforts across urban and rural areas within the eastern territory. Local health centers are receiving personal protective equipment, diagnostic reagents, and therapeutic supplies to bolster readiness. The government reaffirmed that comprehensive public health measures will stay in place until transmission indicators show consistent decline across all impacted provinces.
Officials urged communities to fully cooperate with mobile vaccination teams and follow established health guidelines. Increasing immunization among high-risk populations is expected to stabilize infection rates in the coming weeks. Surveillance systems will continue heightened monitoring at transportation hubs and border crossings to prevent further spread of the virus.